Oracle AI Push targets regulated sectors with new platform and new customers

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million retail investors worldwide.

• Oracle (NYSE:ORCL) has launched a Life Sciences AI Data Platform that uses generative AI to support drug development and clinical research.

• The company also reported new corporate earnings, including IHG Hotels & Resorts for OPERA Cloud in multiple regions.

• Alrajhi Medicine and Voisin Consulting Life Sciences have selected Oracle’s cloud and AI offerings for their regulated operations.

For investors watching NYSE:ORCL, this mix of product news and customer wins sits at the intersection of healthcare, hospitality and regulated services. The Life Sciences AI Data Platform is aimed at pharmaceutical and medical research organizations dealing with complex data and stringent compliance requirements, while OPERA Cloud continues to anchor Oracle’s presence in global hotel operations.

These updates come as large companies look for ways to…